Compare TK & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TK | BBNX |
|---|---|---|
| Founded | 1973 | 2015 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 997.9M |
| IPO Year | 1995 | 2025 |
| Metric | TK | BBNX |
|---|---|---|
| Price | $13.35 | $16.65 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $25.10 |
| AVG Volume (30 Days) | 417.9K | ★ 1.1M |
| Earning Date | 11-11-2026 | 10-27-2026 |
| Dividend Yield | ★ 7.51% | N/A |
| EPS Growth | N/A | ★ 78.95 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $100,251,000.00 |
| Revenue This Year | N/A | $25.22 |
| Revenue Next Year | N/A | $47.09 |
| P/E Ratio | $13.43 | ★ N/A |
| Revenue Growth | N/A | ★ 53.94 |
| 52 Week Low | $8.67 | $8.80 |
| 52 Week High | $15.90 | $32.71 |
| Indicator | TK | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 42.89 | 47.09 |
| Support Level | $13.06 | $15.92 |
| Resistance Level | $14.02 | $18.20 |
| Average True Range (ATR) | 0.56 | 1.65 |
| MACD | -0.13 | 0.03 |
| Stochastic Oscillator | 34.00 | 31.59 |
Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.